Page 9 - பால்டிக் ப்ரொடெக்ஶந் கல்லூரி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பால்டிக் ப்ரொடெக்ஶந் கல்லூரி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பால்டிக் ப்ரொடெக்ஶந் கல்லூரி Today - Breaking & Trending Today

Nasdaq Tallinn: Nasdaq Congratulates Lords LB Baltic Fund IV on Terseta Bond Listing on First North Market


(2)
Vilnius/Riga/Tallinn, Nasdaq Baltic Market, February 25 - Nasdaq (NDAQ)
announces that a bond issue of Terseta UAB, a company owned by investment
management company Lords LB Asset Management s real estate fund Lords LB Baltic
Fund IV, was admitted to trading on the Nasdaq Baltic First North bond market
by Nasdaq Vilnius on February 25.
The size of the Terseta bond issue is EUR 8 million. The nominal value of one
bond is EUR 100. With a maturity of 18 months, the securities pay interest
every 6 months at an annual rate of 6%. Their redemption date is June 10, 2022.
We congratulate Lords LB Asset Management on the listing of bonds issued by ....

Vilniaus Apskritis , Kostenloser Wertpapierhandel , Daiva Tauckelaite , Saulius Malinauskas , Rytis Zaloga , Exchange Commission , Lords Lb Baltic Fund , Management Company , Nasdaq Baltic Market , Nasdaq Baltic First North , Nasdaq Vilnius , Baltic First North , Asset Management , First North , Nasdaq First North , Nasdaq Tallinn , Nasdaq Riga , Note Regarding Forward Looking Statements , Safe Harbor , Private Securities Litigation Reform Act , Relations Contacts , பரிமாற்றம் தரகு , பிரபுக்கள் எல்பி பால்டிக் நிதி , மேலாண்மை நிறுவனம் , நாஸ்டாக் பால்டிக் சந்தை , நாஸ்டாக் பால்டிக் முதல் வடக்கு ,

Nasdaq Riga: Nasdaq Congratulates Lords LB Baltic Fund IV on Terseta Bond Listing on First North Market


(2)
Vilnius/Riga/Tallinn, Nasdaq Baltic Market, February 25, - Nasdaq (NDAQ)
announces that a bond issue of Terseta UAB, a company owned by investment
management company Lords LB Asset Management s real estate fund Lords LB Baltic
Fund IV, was admitted to trading on the Nasdaq Baltic First North bond market
by Nasdaq Vilnius on February 25.
The size of the Terseta bond issue is EUR 8 million. The nominal value of one
bond is EUR 100. With a maturity of 18 months, the securities pay interest
every 6 months at an annual rate of 6%. Their redemption date is June 10, 2022.
We congratulate Lords LB Asset Management on the listing of bonds issued by ....

Vilniaus Apskritis , Kostenloser Wertpapierhandel , Daiva Tauckelaite , Saulius Malinauskas , Rytis Zaloga , Exchange Commission , Lords Lb Baltic Fund , Management Company , Nasdaq Baltic Market , Nasdaq Baltic First North , Nasdaq Vilnius , Baltic First North , Asset Management , First North , Nasdaq First North , Nasdaq Tallinn , Nasdaq Riga , Note Regarding Forward Looking Statements , Safe Harbor , Private Securities Litigation Reform Act , Relations Contact , பரிமாற்றம் தரகு , பிரபுக்கள் எல்பி பால்டிக் நிதி , மேலாண்மை நிறுவனம் , நாஸ்டாக் பால்டிக் சந்தை , நாஸ்டாக் பால்டிக் முதல் வடக்கு ,

Drug-Coated Balloons Market | Industry Size, Share, Analysis, Price, Report and Forecast To 2027


(MENAFN - Comserve) Shibuya-ku, Tokyo, Japan, Japan, Feb 18, 2021, 09:43 /Comserve / Competitive Analysis: Acotec Scientific, M.A. Med Alliance, ENDOCOR, AR Baltic Medical, iVascular SLU, Concept Medical, Acrostak, Hexacath, Cardionovum, Biosensors International Group
Drug-Coated Balloons Market by Indication (DCB for Peripheral Artery Disease, DCB for Coronary Artery Disease, DCB for Other Indications) Application (Cardiac Catheterization Labs, Hospitals, ASCs) - Global Industry Analysis & Forecast to 2025
Industry Outlook and Trend Analysis
The drug-coated balloons market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Drug-coated balloons (DCBs) are standard (semi-agreeable) angioplasty balloons covered with a cytotoxic chemotherapeutic specialist. Presently, most of commercially accessible drug-coated balloons use paclitaxel. Drug-coated balloons (DCB) are a novel therapeutic proce ....

United States , United Kingdom , South Africa , United Arab Emirates , Saudi Arabia , South Korea , Comserve Shibuya Ku , Ma Med Alliance , Biosensors International Group , Acotec Scientific , Concept Medical , Biosensors International , Coated Balloons Market , Peripheral Artery Disease , Coronary Artery Disease , Cardiac Catheterization Labs , Industry Analysis , Sample Copy , Final Report , Global And Regional Market , States Market Status , Market Status , Kingdom Market Status , Europe Market Status , Southeast Asia , Asia Market Status ,